Two-Hour Insulin Determination Improves the Ability of Abdominal Fat Measurement to Identify Risk for the Metabolic Syndrome

Two-Hour Insulin Determination Improves the Ability of Abdominal Fat Measurement to Identify Risk for the Metabolic Syndrome Fernando F. Ribeiro-Filho , MD, PHD 1 , Alessandra N. Faria , MD, PHD 1 , Narcia E.B. Kohlmann , RN 2 , Maria-Teresa Zanella , MD, PHD 1 and Sandra R.G. Ferreira , MD, PHD 3 1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes care 2003-06, Vol.26 (6), p.1725-1730
Hauptverfasser: RIBEIRO-FILHO, Fernando F, FARIA, Alessandra N, KOHLMANN, Narcia E. B, ZANELLA, Maria-Teresa, FERREIRA, Sandra R. G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Two-Hour Insulin Determination Improves the Ability of Abdominal Fat Measurement to Identify Risk for the Metabolic Syndrome Fernando F. Ribeiro-Filho , MD, PHD 1 , Alessandra N. Faria , MD, PHD 1 , Narcia E.B. Kohlmann , RN 2 , Maria-Teresa Zanella , MD, PHD 1 and Sandra R.G. Ferreira , MD, PHD 3 1 Endocrinology Division, the Department of Internal Medicine, Federal University of São Paulo, São Paulo, Brazil 2 Nephrology Division, Department of Internal Medicine, Federal University of São Paulo, São Paulo, Brazil 3 Department of Preventive Medicine, Federal University of São Paulo, São Paulo, Brazil Abstract OBJECTIVE —Visceral obesity is shown to be a predictor of morbidity and mortality. We evaluated the association of measurements of generalized adiposity and visceral fat area (VFA), with abnormalities of metabolic syndrome (MS). RESEARCH DESIGN AND METHODS —Seventy-six women (47.9 ± 9.2 years) with BMI of 38.7 ± 5.4 kg/m 2 underwent anthropometric measurements, laboratory procedures, bioeletrical impedance, and abdominal computed tomography (CT) scan. Diagnosis of MS was based on the presence of abdominal obesity and at least two of the following components: hypertension, dyslipidemia, and glucose intolerance and/or hyperinsulinemia. RESULTS —BMI was correlated with both components of adipose tissue—subcutaneous ( r = 0.66, P < 0.01) and VFA ( r = 0.33, P < 0.02)—and leptin levels ( r = 0.38, P < 0.01). In contrast, VFA was correlated with 2-h glucose and insulin levels ( r = 0.32 and 0.35, P < 0.05, respectively), triglyceride, HDL cholesterol, and uric acid ( r = 0.33, −0.34 and 0.24, P < 0.05, respectively). Subjects with high VFA, matched for BMI, showed greater plasma glucose area under the curve (621 ± 127 vs. 558 ± 129 mg · h −1 · dl −1 , P < 0.05), 2-h insulin (804 ± 599 vs. 579 ± 347 pmol/l, P < 0.05), and uric acid levels (0.33 ± 0.07 vs. 0.26 ± 0.06 mmol/l, P < 0.05) than subjects with low VFA. In logistic regression analysis, waist circumference, VFA, and 2-h insulin were identified as independent predictors of MS. Receiver operating characteristic curve analysis pointed out the values of 104 cm for waist circumference (58.1% specificity, 84.1% sensitivity), 158.5 cm 2 for VFA (78.1% specificity, 52.3% sensitivity), and 559.8 pmol/l for 2-h insulin (71.9% specificity, 69.8% sensitivity); the presence of at least two of the three variables resulted in a degree of concordance of 76%. CONCLUSIONS —While BMI was unable to differentiate between
ISSN:0149-5992
1935-5548
DOI:10.2337/diacare.26.6.1725